Carter, A M <br/><br/>
Metformin reduces C-reactive protein but not complement factor C3 in overweight patients with Type 2 diabetes mellitus.  [electronic resource] 

 -  Diabetic medicine : a journal of the British Diabetic Association  Sep 2005 
 - 1282-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0742-3071 
<br/><br/><label>Standard No.: </label>10.1111/j.1464-5491.2005.01632.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>C-Reactive Protein--analysis<br/>Complement C3--analysis<br/>Diabetes Mellitus, Type 2--blood<br/>Double-Blind Method<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Metformin--therapeutic use<br/>Obesity--blood